Two new vaccines studies from PHE bring encouraging news on protection against hospitalisation and death. But they leave me with more questions than answers.
The post Majority of Covid Hospital Admissions Over Winter Were Vaccinated, PHE Study Shows appeared first on Lockdown Sceptics.
A new population study from Israel published in the Lancet finds that the Pfizer vaccine is 95% effective once a person is fully vaccinated. But have they taken into account that infections were falling anyway?
The post Study Claims Pfizer Vaccine is 95% Effective in Over 65s. But Should That Be 74%? appeared first on Lockdown Sceptics.
Principia Scientific | May 6, 2021 You first heard of ‘too big to fail’ banks in 2008 when the global economic collapse destroyed lives and businesses and few, if any fraudster bankers went to jail. Don’t be surprised to learn that ‘too big to fail‘ also applies to those Big Pharma entities in cahoots with corrupt politicians. […]
Dr. Mercola | Although the short-term harmful effects of COVID-19 vaccines are being reported at a staggering rate - the long-term effects are completely unknown.
Perspectives on the Pandemic | This is a criminal enterprise, the likes of which this world has never seen before.
21WIRE | It’s a conspiracy theory - until a Big Pharma boss admits he's doing it.
Suzie Halewood In 1956 German pharmaceutical company Chemie Grünenthal GmbH, licensed a new experimental drug designed to treat colds, flu, nausea and morning sickness. Known as Distaval in the UK, Distillers Biochemicals Ltd declared the drug could ‘be given with complete safety to pregnant women and nursing mothers without adverse effect on mother or child’ …
The E.U. will soon seal its departure from the AstraZeneca Covid vaccine by signing off on the world's biggest vaccine deal yet, buying up to 1.8 billion doses of the Pfizer vaccine to last up until 2023.
The post E.U. Orders 1.8 Billion Doses of Pfizer’s Covid Vaccine appeared first on Lockdown Sceptics.
21WIRE | Another pharma giant is forced to hit the brakes on the experimental vaccine product.
One of the reasons the government wanted Pfizer’s vaccines was because the company said they could be delivered quickly. Yet in the contract, Pfizer wanted to reserve the right to modify the schedule. There was no room for negotiation. “It was take it or leave it,” said the official.
